AIM ImmunoTech (AIM) EPS (Basic) Growth (1y) (2011 - 2026)
AIM ImmunoTech (AIM) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | -16.29% |
| 10 | AIM ImmunoTech | 4.50 Mn | -5.46 Mn | 21,000.00 | 93.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 88.86% |
| Mar 31, 2026 | 86.34% |
| Dec 31, 2025 | 81.31% |
| Sep 30, 2025 | 84.58% |
| Jun 30, 2025 | 45.75% |
| Mar 31, 2025 | 67.70% |
| Dec 31, 2024 | 63.28% |
| Sep 30, 2024 | 52.50% |
| Jun 30, 2024 | -2.47% |
| Mar 31, 2024 | -80.85% |
| Dec 31, 2023 | -148.26% |
| Sep 30, 2023 | -22.28% |
| Jun 30, 2023 | -15.67% |
| Mar 31, 2023 | -33.37% |
| Dec 31, 2022 | 25.45% |
| Sep 30, 2022 | -132,403.78% |
| Jun 30, 2022 | -4.17% |
| Mar 31, 2022 | 17.81% |
| Dec 31, 2021 | -7.95% |
| Sep 30, 2021 | 99.88% |